| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | A |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | B |
| 8. Outlier Analysis | B |
| 9. Normality | A |
| 10. Variance Homogeneity | A |
| 11. ANOVA | A |
| 12. CI | A |
| 13. No of Results | A |
| 14. Concentrations | A |
| 15. Total Score | B7,8 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Cancer antigen 125 (CA-125) |
| Unit | ku / L |
| Overall Analytical Principle Method | Immunoassay; Not specified |
| Number of Subjects | 28 |
| Number of Subjects included in BV estimation | 28 |
| Ethinicity | Caucasian |
| Age Mean / Median | |
| Age Min | 25.0 |
| Age Max | 68.0 |
| Age SD | |
| Number of Males | 0 |
| Number of Females | 28 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 4 |
| Study Duration Units | Month |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 1 |
| Interval Units | Month |
| Sampling Times | Start Time:
09:00
End Time: 09:30 |
| Number of Samples | 4 |
| Average Number of Samples Used for BV Estimation | 4.0 |
| Average Number of Replicates | 2.0 |
| Estimates of CVi | 9.1 |
| Calculated Confidence Intervals of CVi | Lower: 7.88, Upper: 10.75 |
| Estimates of CVg | 10.6 |
| Calculated Confidence Intervals of CVg | Lower: 7.88, Upper: 14.93 |
| Analytical CV | 1.97 |
| Calculated Confidence Intervals of Analytical CV | Lower: 1.74, Upper: 2.27 |
| Measurand Mean | 12.3 |
| Measurand Min | 2.5 |
| Measurand Max | 35.8 |
| Measurand SD |